AFL

AFL

USD

AFLAC Incorporated Common Stock

$105.530+1.170 (1.121%)

Preço em tempo real

Serviços financeiros
Insurance - Life
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$104.360

Máximo

$106.035

Mínimo

$103.965

Volume

0.25M

Fundamentos da empresa

Capitalização de mercado

57.2B

Setor

Insurance - Life

País

United States

Estatísticas de negociação

Volume médio

2.13M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $83.27Atual $105.530Máximo $115.5

Relatório de análise de IA

Última atualização: 25/04/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

AFL: AFLAC Incorporated Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: AFL Generate Date: 2025-04-25 07:34:21

Let's take a look at what's been going on with AFLAC lately and what the data we have might suggest.

What the News is Saying

The buzz around AFLAC from recent headlines is a bit of a mixed bag, leaning towards analyst opinions and an important upcoming event.

One piece of news touched on the general importance of health checkups, which makes sense for a company like AFLAC that sells supplemental health insurance. While it highlights the need for their products, it's not really specific news about the company's performance right now.

More directly impacting the stock are the analyst ratings. We've seen a few updates:

  • Morgan Stanley lowered their price target slightly, moving it from $105 to $100, while keeping their "Equal-Weight" rating.
  • On the flip side, UBS raised their target from $109 to $114, sticking with "Neutral."
  • Piper Sandler also bumped their target up significantly, from $118 to $124, maintaining their "Overweight" rating.
  • JP Morgan nudged their target up a bit too, from $94 to $96, staying "Neutral."

So, analysts seem to have differing views, with some seeing more upside than others, but one firm did lower their outlook.

The really big news is that AFLAC is set to release its first-quarter financial results after the market closes on April 30th. They'll also host a webcast on May 1st. This is a key date because the actual numbers will give investors a much clearer picture of how the company is doing.

Checking the Price Chart

Looking back at the last few months of price data, AFLAC's stock had a pretty good run from late January through March, climbing from around $105 up past $111. But then things got choppy in early April. We saw a pretty sharp dip, with the price briefly falling below $100 around April 7th.

Since that dip, the stock has recovered some ground. It's been trading in the $108 to $109 range over the last few days of the data we have. The last recorded closing price was $109.14. So, it's bounced back from the early April low but is still below its recent highs from late March.

What the AI Thinks

Our AI model has some specific predictions for the very near term. It's forecasting a drop today, predicting the price will be down about 2.49%. For tomorrow, it sees a small bounce back, up around 0.53%. But then, the day after that, it predicts another, larger drop of about 3.12%.

Overall, the AI seems to be calling for some downward pressure on the stock price in the immediate future. The AI prediction score and direction also lean negative. It even points to a potential support level around $98.83, which is close to that low point we saw in early April.

Putting It All Together: Outlook & What to Watch

Based on the news, recent price moves, and the AI's forecast, the picture for AFLAC right now looks a bit uncertain, especially in the very short term.

  • Overall Lean: The analyst opinions are split, the price has been volatile recently (a sharp dip followed by a recovery), and the AI is predicting near-term declines. Plus, the big earnings report is just around the corner. All this suggests a "wait and see" approach might be sensible right now. It's hard to make a strong call either way before those earnings numbers come out.
  • Potential Levels to Watch:
    • Given the AI's prediction of a dip, you might watch to see if the stock approaches that $98.83 level the AI mentioned, or perhaps the recent low around $97.50 from early April. These could act as support if the price falls, but there's no guarantee.
    • On the upside, the recent high around $111-$112 could act as resistance. The take-profit level suggested in some data is $110.59, which fits in this area.
    • For managing risk if you currently hold the stock, a potential stop-loss level mentioned is $105.25. This is below the current price and recent trading range, suggesting a point where you might reconsider holding if it drops significantly.

The upcoming earnings report on April 30th is the most important thing to watch. That will likely be the next major driver of the stock price. Until then, things could be choppy, especially if the AI's prediction of near-term drops plays out.

A Bit About the Company

Just to remember, AFLAC is primarily in the business of selling supplemental health and life insurance. This means things like cancer, disability, and accident policies. They operate in both the U.S. and Japan. Their business performance is tied to factors like employment levels (people buying insurance through work) and healthcare trends. The news about people putting off checkups, while not directly about AFLAC, does highlight the health landscape they operate in.


Important Note: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are unpredictable, and prices can go down as well as up. You should always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Notícias relacionadas

Analyst Upgrades

Barclays Maintains Underweight on Aflac, Raises Price Target to $96

Barclays analyst Alex Scott maintains Aflac with a Underweight and raises the price target from $95 to $96.

Ver mais
Barclays Maintains Underweight on Aflac, Raises Price Target to $96
PR Newswire

Aflac Incorporated Announces First Quarter Results, Reports First Quarter Net Earnings of $29 Million, Declares Second Quarter Dividend

Aflac Incorporated (NYSE: AFL) today reported its first quarter results. Total revenues were $3.4 billion in the first quarter of 2025, compared with ...

Ver mais
Aflac Incorporated Announces First Quarter Results, Reports First Quarter Net Earnings of $29 Million, Declares Second Quarter Dividend
PR Newswire

9 in 10 Americans have put off health checkups and screenings that could help save their lives

April is National Cancer Prevention and Early Detection Month, a time to emphasize the importance of preventive health care and the value of early...

Ver mais
9 in 10 Americans have put off health checkups and screenings that could help save their lives
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Aflac, Lowers Price Target to $100

Morgan Stanley analyst Nigel Dally maintains Aflac with a Equal-Weight and lowers the price target from $105 to $100.

Ver mais
Morgan Stanley Maintains Equal-Weight on Aflac, Lowers Price Target to $100

Previsão de IABeta

Recomendação de IA

Baixista

Atualizado em: 3/05/2025, 07:56

BaixistaNeutroAltista

57.7% Confiança

Risco e negociação

Nível de risco3/5
Risco médio
Adequado para
Conservador
Guia de negociação

Ponto de entrada

$105.39

Tomar lucro

$107.64

Parar perda

$102.34

Fatores-chave

DMI mostra tendência de baixa (ADX:21.8, +DI:4.7, -DI:5.2), sugerindo cautela
O preço atual está extremamente próximo do nível de suporte ($105.60), sugerindo forte oportunidade de compra
O volume de negociação é 7.6x a média (19,469), indicando pressão de compra extremamente forte
MACD 0.0994 está abaixo da linha de sinal 0.1174, indicando um crossover de baixa

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.